One-Pot Synthesis of Pyrrolo[3,4-a]indolizine-1,3-diones through [3+2] Cycloaddition-Oxidation Reaction Catalyzed by CuII Salt and O2 as the Oxidant

被引：18

作者：

Liu, Yun ^{[1
,2
]}

Hu, Hua-You ^{[3
]}

Su, Xian-Bin ^{[4
]}

Sun, Jin-Wei ^{[1
,2
]}

Cao, Chang-Sheng ^{[1
,2
]}

Shi, Yan-Hui ^{[1
,2
]}

机构：

[1] Jiangsu Normal Univ, Dept Chem & Chem Engn, Xuzhou 221116, Jiangsu, Peoples R China

[2] Jiangsu Normal Univ, Jiangsu Key Lab Green Synthet Chem Funct Mat, Xuzhou 221116, Jiangsu, Peoples R China

[3] Huaiyin Normal Univ, Sch Chem & Chem Engn, Jiangsu Key Lab Chem Low Dimens Mat, Huaian 223300, Jiangsu, Peoples R China

[4] Nanjing Univ Technol, Dept Chem & Chem Engn, Nanjing 211816, Jiangsu, Peoples R China

来源：

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY | 2013年 / 2013卷 / 10期

基金：

中国国家自然科学基金;

关键词：

Synthetic methods; Homogeneous catalysis; Copper; Cycloaddition; Oxidation; Nitrogen heterocycles; HETEROAROMATIC N-YLIDES; INDOLIZINE DERIVATIVES; IN-VIVO; INHIBITORS; CASTANOSPERMINE; ANALOGS; MICE;

D O I：

10.1002/ejoc.201201488

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

An efficient one-pot synthesis of pyrrolo[3,4-a]indolizine-1,3-diones has been developed from maleimides, pyridines, and acyl bromides through a [3+2] cyclization-oxidation reaction catalyzed by Cu-II salt under O-2 atmosphere. The advantage of this method is the use of molecular oxygen as the oxidant, in the presence of a catalytic amount of hydrated copper(II) chloride, to accomplish the reaction with broad substrate scope and excellent yields.

引用

页码：2020 / 2026

页数：7

共 38 条

[1] 5-HYDROXYTRYPTAMINE (5-HT3) RECEPTOR ANTAGONISTS .1. INDAZOLE AND INDOLIZINE-3-CARBOXYLIC ACID-DERIVATIVES
BERMUDEZ, J
FAKE, CS
JOINER, GF
JOINER, KA
KING, FD
MINER, WD
SANGER, GJ
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (07) : 1924 - 1929
[2] Non-imidazole heterocyclic histamine H3 receptor antagonists
Chai, WY
Breitenbucher, JG
Kwok, A
Li, XB
Wong, V
Carruthers, NI
Lovenberg, TW
Mazur, C
Wilson, SJ
Axe, FU
Jones, TK
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (10) : 1767 - 1770
[3] CHATELAIN P, 1992, CARDIOSCIENCE, V3, P117
[4] Synthesis of the angiotensin-converting enzyme inhibitors (-)-A58365A and (-)-A58365B from a common intermediate
Clive, DLJ
Coltart, DM
Zhou, YX
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (05) : 1447 - 1454
[5] Privileged structures: Applications in drug discovery
DeSimone, RW
Currie, KS
Mitchell, SA
Darrow, JW
Pippin, DA
[J]. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2004, 7 (05) : 473 - 493
[6] Flitsch W., 1984, Comprehensive Heterocyclic Chemistry, II, V8, P237
[7] Homogeneous bio-inspired copper-catalyzed oxidation reactions
Gamez, P
Aubel, PG
Driessen, WL
Reedijk, J
[J]. CHEMICAL SOCIETY REVIEWS, 2001, 30 (06) : 376 - 385
[8] INTERFERENCE WITH HIV-INDUCED SYNCYTIUM FORMATION AND VIRAL INFECTIVITY BY INHIBITORS OF TRIMMING GLUCOSIDASE
GRUTERS, RA
NEEFJES, JJ
TERSMETTE, M
DEGOEDE, REY
TULP, A
HUISMAN, HG
MIEDEMA, F
PLOEGH, HL
[J]. NATURE, 1987, 330 (6143) : 74 - 77
[9] NOVEL HETEROCYCLIC-ANALOGS OF THE NEW POTENT CLASS OF CALCIUM ENTRY BLOCKERS - 1-[[4-(AMINOALKOXY)PHENYL]SULFONYL]INDOLIZINES
GUBIN, J
DEVOGELAER, H
INION, H
HOUBEN, C
LUCCHETTI, J
MAHAUX, J
ROSSEELS, G
PEIREN, M
CLINET, M
POLSTER, P
CHATELAIN, P
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (10) : 1425 - 1433
[10] Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis
Gundersen, Lise-Lotte
Charnock, Colin
Negussie, Ayele Hailu
Rise, Frode
Teklu, Solomon
[J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 30 (01) : 26 - 35

← 1 2 3 4 →